To assess the clinical efficacy and safety of denosumab in the prevention and treatment of osteoporosis compared to placebo or active comparator in postmenopausal women.
This is a protocol.
To assess the clinical efficacy and safety of denosumab in the prevention and treatment of osteoporosis compared to placebo or active comparator in postmenopausal women.
This is a protocol.